Wei Sang Selected Research

Wei Sang Research Topics

Disease

39	Neoplasms (Cancer) 04/2024 - 08/2013
16	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2023 - 08/2018
14	Multiple Myeloma 04/2024 - 10/2019
12	Lymphoma (Lymphomas) 12/2023 - 09/2019
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 04/2016
7	Glioma (Gliomas) 01/2023 - 12/2019
6	Cytokine Release Syndrome 04/2024 - 01/2020
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 05/2011
5	Infections 12/2023 - 10/2014
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 06/2021
3	Inflammation (Inflammations) 01/2023 - 06/2021
3	Leukemia 01/2022 - 01/2018
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 05/2011
2	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2023 - 08/2022
2	Hypoxia (Hypoxemia) 04/2023 - 02/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2019
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 11/2020
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 09/2016
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2015 - 06/2012
1	cell-associated neurotoxicity 04/2024
1	Obesity 03/2024
1	Overweight 03/2024
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024
1	Epstein-Barr Virus Infections 12/2023
1	Melanoma (Melanoma, Malignant) 04/2023
1	Carcinogenesis 04/2023
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Bites and Stings (Sting) 03/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022

Drug/Important Bio-Agent (IBA)

29	Chimeric Antigen ReceptorsIBA 04/2024 - 01/2018
8	Proteins (Proteins, Gene)FDA Link 10/2023 - 08/2014
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2019
6	CytokinesIBA 02/2023 - 06/2012
5	MetalsIBA 01/2023 - 02/2021
5	PolyphenolsIBA 03/2022 - 10/2019
4	B-Cell Maturation AntigenIBA 04/2024 - 10/2019
4	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 04/2024 - 10/2019
4	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 01/2020
4	Rituximab (Mabthera)FDA Link 01/2022 - 01/2021
3	AntigensIBA 04/2024 - 01/2021
3	tocilizumab (atlizumab)FDA Link 04/2024 - 01/2021
3	Hemoglobins (Hemoglobin)IBA 03/2024 - 02/2021
3	Ferritins (Ferritin)IBA 01/2023 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 06/2021
3	Asparaginase (Elspar)FDA Link 08/2022 - 10/2019
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2024 - 01/2023
2	Messenger RNA (mRNA)IBA 01/2024 - 01/2022
2	PolymersIBA 04/2023 - 10/2019
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2023 - 10/2021
2	GlucocorticoidsIBA 01/2023 - 01/2022
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 01/2022
2	Oxygen (Dioxygen)IBA 01/2022 - 02/2021
2	Single-Chain AntibodiesIBA 01/2022 - 01/2018
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2022 - 06/2021
2	HafniumIBA 11/2021 - 02/2021
2	MicroRNAs (MicroRNA)IBA 11/2021 - 10/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 02/2021
2	polysulfideIBA 06/2021 - 10/2017
2	ELAV-Like Protein 2IBA 11/2020 - 02/2020
2	ParaffinIBA 11/2020 - 08/2013
2	Inosine Triphosphate (ITP)IBA 10/2015 - 06/2012
2	Complementary DNA (cDNA)IBA 10/2015 - 06/2015
1	E2F Transcription FactorsIBA 01/2024
1	Tenofovir (Viread)FDA Link 12/2023
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 12/2023
1	CPI-0610IBA 10/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2023
1	Serum AlbuminIBA 08/2023
1	catechol (pyrocatechol)IBA 04/2023
1	PlatinumIBA 04/2023
1	LigandsIBA 04/2023
1	CalciumIBA 01/2023
1	BilirubinIBA 01/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	Hyaluronic Acid (Hyaluronan)IBA 01/2023
1	tislelizumabIBA 01/2023
1	Apoptosis Regulatory ProteinsIBA 01/2023
1	Alanine Transaminase (SGPT)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 01/2023
1	ThymosinIBA 01/2023
1	GSK2837808AIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Lactate Dehydrogenase 5IBA 01/2023
1	Indicators and Reagents (Reagents)IBA 10/2022
1	Etoposide (VP 16)FDA LinkGeneric 08/2022
1	Drug CombinationsIBA 08/2022
1	InterferonsIBA 03/2022
1	NaGdF4IBA 03/2022
1	Lanthanoid Series Elements (Lanthanides)IBA 03/2022
1	carboxyl radical (COO-)IBA 01/2022

Therapy/Procedure

26	Therapeutics 04/2024 - 09/2019
11	Immunotherapy 04/2024 - 07/2019
7	Hematopoietic Stem Cell Transplantation 01/2023 - 05/2011
6	Radiotherapy 04/2023 - 08/2014
5	Drug Therapy (Chemotherapy) 12/2023 - 08/2014
2	Photothermal Therapy 11/2021 - 06/2021
2	Transplantation 01/2021 - 05/2011